Source link : https://www.newshealth.biz/health-news/skip-surgery-for-dcis-in-favor-of-active-monitoring/
SAN ANTONIO — Active monitoring for low-risk ductal carcinoma in situ (DCIS) did not lead to a higher rate of ipsilateral invasive cancer versus guideline-recommended treatment, the randomized COMET trial showed. The 2-year cumulative rate of invasive cancer in the same breast was 4.2% with active monitoring and 5.9% with standard-of-care treatment. The difference did […]
Author : News Health
Publish date : 2024-12-12 20:27:27
Copyright for syndicated content belongs to the linked Source.
inHealth